Starting Aripiprazole After Risperidone 2mg BID
Start aripiprazole at 10 mg once daily while simultaneously discontinuing risperidone 2mg BID. This approach is supported by FDA labeling and allows for a straightforward switch without complex cross-titration.
Recommended Starting Dose
The FDA-approved starting dose for aripiprazole in schizophrenia is 10 or 15 mg once daily 1. Based on the evidence:
- 10 mg/day is the optimal starting dose for most patients, as this represents the threshold for clinical effect and produces the highest response rates 2, 3
- The patient's current risperidone dose (2mg BID = 4mg total daily) is within the therapeutic range, suggesting stable symptomatology that can transition to aripiprazole 10mg
- Doses below 10mg (except for agitation management) have not shown significant efficacy on core schizophrenia symptoms 3
Switching Strategy
Immediate discontinuation of risperidone with same-day initiation of aripiprazole 10mg is appropriate 4. A multicenter study demonstrated that immediate switching (stopping the current antipsychotic while simultaneously starting aripiprazole 30mg) was safe and effective, with maintained efficacy and comparable tolerability across different switching strategies 4.
Key Points for This Switch:
- No oral supplementation needed when switching from oral risperidone to oral aripiprazole (supplementation is only required when initiating aripiprazole LAI) 1
- The patient is already on a relatively low dose of risperidone (4mg total daily), which reduces risk of symptom exacerbation during the switch
- Aripiprazole reaches peak plasma concentrations within 3-5 hours and has 87% oral bioavailability 5
Dosing Considerations
Do not start higher than 10mg initially, even though the FDA label mentions 10-15mg as starting options 1:
- Research consistently shows 10mg/day produces optimal response rates in schizophrenia 2, 3
- Doses above 20mg provide no additional benefit and may be associated with smaller symptom improvements 2
- Starting at 10mg allows assessment of response before any upward titration
- If dose adjustment is needed, wait at least 2 weeks (time to steady-state) before increasing 1
Monitoring During Transition
Watch for:
- Extrapyramidal symptoms (EPS): Aripiprazole has lower EPS risk than risperidone, so the patient may experience improvement in any existing movement side effects 6, 7
- Akathisia: This is the most common side effect with aripiprazole and may emerge during the first 2 weeks 1
- Metabolic improvements: Expect potential weight loss and prolactin normalization when switching from risperidone to aripiprazole 4
- Symptom stability: Monitor for any breakthrough psychotic symptoms, though this is uncommon with immediate switching strategies 4
Special Circumstances
If the patient is a CYP2D6 poor metabolizer or taking strong CYP2D6/3A4 inhibitors, consider starting at 5mg daily and titrating to 10mg 1. However, without this information, proceed with standard 10mg dosing.
If switching due to side effects (particularly metabolic or prolactin-related), the immediate switch strategy is preferable as it allows faster resolution of these issues 4.